RecruitingNot ApplicableNCT06411990

Laser In Situ Fenestration Study

Laser In Situ Fenestration for Endovascular Aortic Repair (LIFE) Study


Sponsor

Jonathan Bath

Enrollment

15 participants

Start Date

Oct 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn about a new device, named the LIFE device, to treat people with aneurysms (swellings) in the aorta (large, main blood vessel that delivers blood from the heart to the body). The main questions this trial aims to answer are: * If the LIFE device works to treat aortic aneurysms * What medical problems participants have when the LIFE device is used Participants will undergo treatment with the LIFE device and thereafter at 30 days, 6 months, 1 year, 2 years, 3 years, 4 years, and 5 years have their pulses checked, bloodwork to check kidney function (BUN and serum creatinine), and a CT scan of the aneurysm area.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Fenestrated Endovascular Aneurysm Repair using the LIFE Device System for people with aortic aneurysm and endovascular aneurysm repair. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEFenestrated Endovascular Aneurysm Repair using the LIFE Device System

Fenestrated Endovascular Aneurysm Repair


Locations(1)

University of Missouri - Columbia

Columbia, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06411990


Related Trials